New deal
ReSolved Technologies: “Confidence in the product and the partnership!”
28.11.2025
We move markets through meaningful impact.
Our mission
We invest in visionary founders leveraging science and innovation to build breakthrough technologies that future-proof essential systems.
About us
Our portfolio
Vantly
Pharmacell
Enzypep
SkuB
Black Bear Carbon
Citenfor
Afferm
Noventtis Technologies
Basic Pharma
QC Polymers
We invest in visionary founders leveraging science and innovation to build breakthrough technologies that future-proof essential systems.
Full portfolio
Our impact
We focus on lasting impact
Every investment begins with the same question: will this make the world healthier and more sustainable? We believe progress and responsibility must evolve together. Impact is not an afterthought or a side metric. It shapes how we select, support, and scale every company we back.
Founder perspective
“ BVP never tried to run our company. They asked the right questions, pushed when it mattered, and gave us the space to grow.”
“ BVP never tried to run our company. They asked the right questions, pushed when it mattered, and gave us the space to grow.”
“ BVP never tried to run our company. They asked the right questions, pushed when it mattered, and gave us the space to grow.”
BVP in a nutshell
Nearly two decades of focused investing have built a foundation of insight, momentum, and meaningful wins. These numbers tell the story.
AUM
€120M
Assets under management
Companies screened
1.000+
Yearly average
Years of investing
20+
Established in 2005
Funds raised
4
Breakthrough chemistry and materials.
Portfolio companies
40+
Early regional innovation